USTR’s Report Targets Trade Barriers to Biotech

This article was originally published here

The Office of the United States Trade Representative’s (USTR) annual Special 301 Report identifies trade barriers to U.S. companies and products due to the intellectual property (IP) laws. Each year the USTR identifies countries which do not appropriately administer intellectual property rights.

This year’s report addresses many of the key IP-related challenges that BIO members face globally, including inadequate legal protections, enforcement issues, restrictive patentability criteria, lengthy patent backlogs, and the threat of outright expropriation of U.S. intellectual property rights through compulsory licensing.

Read BIO’s full statement on the USTR’s 2017 “Special 301 Report”

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply